BRANDT GORDON 4
4 · NASTECH PHARMACEUTICAL CO INC · Filed Jan 25, 2005
Insider Transaction Report
Form 4
BRANDT GORDON
Exec VP of Science and Clinica
Transactions
- Award
Nastech Pharmaceutical Co. Common Stock
2005-01-21+7,500→ 7,500 total - Award
Nastech Pharmaceutical Company Stock Options
2005-01-21$10.39/sh+7,500$77,925→ 122,500 totalExercise: $10.39From: 2006-01-21Exp: 2015-01-21→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]N/A - restricted stock award